×
App Icon
The Standard e-Paper
Kenya’s Boldest Voice
★★★★ - on Play Store
Download App

Lancet retracts study on use of anti-malarial drug for Covid-19 treatment

A nurse shows a pill of hydroxychloroquine, amid the coronavirus disease (COVID-19) outbreak, at Nossa Senhora da Conceicao hospital in Porto Alegre, Brazil, April 23, 2020. [Photo:Reuters]


The lancet a renowned medical journal has retracted a study that sparked conversations and raised concerns on the safety of the experimental chloroquine and hydroxychloroquine that were being used for experimental Covid-19 treatments after scrutiny of the data underlying the paper.

According to Lancet, the publication analysis and data was conducted by Surgisphere Corporation and Sapan Desai Lancet's co-author.

Get Full Access for Ksh299/Week.
Uncover the stories others won’t tell. Subscribe now for exclusive access
  • Unlimited access to all premium content
  • Uninterrupted ad-free browsing experience
  • Mobile-optimized reading experience
  • Weekly Newsletters
  • MPesa, Airtel Money and Cards accepted
Already a subscriber? Log in